Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis. 1996

M Saetta, and A Di Stefano, and P Maestrelli, and G Turato, and C E Mapp, and M Pieno, and G Zanguochi, and G Del Prete, and L M Fabbri
Institute of Occupational Medicine, University of Padova, Italy.

BACKGROUND An increased number of eosinophils in the bronchial mucosa has been demonstrated both in asthma and in exacerbations of chronic bronchitis. OBJECTIVE To investigate whether the airway eosinophilia present in asthma and in chronic bronchitis during exacerbations is associated with interleukin (IL)-5 protein expression in the bronchial mucosa. METHODS We obtained bronchial biopsies in 18 subjects with asthma (four intrinsic, seven extrinsic and seven occupational) and in 11 subjects with chronic bronchitis examined during an exacerbation. The findings were compared with those of bronchial biopsies from 10 subjects with chronic bronchitis examined under baseline conditions and from seven normal subjects, taken as controls. By immunohistochemistry, we assessed the expression of IL-5 protein and the number of eosinophils (EG2), mast cells (tryptase), and T-lymphocytes (CD3) in the submucosa. RESULTS As compared with controls, the number of eosinophils was increased to a similar degree in both asthma (P < 0.001) and in exacerbations of chronic bronchitis (P < 0.001), whereas the number of IL-5 immunopositive cells was increased significantly only in asthma (P < 0.01). No differences were observed in the number of mast cells and T-lymphocytes between the four groups of subjects examined. CONCLUSIONS This study shows that the degree of airway eosinophilia is similar in asthma and in exacerbations of chronic bronchitis, but only in asthma is it associated with an increased expression of IL-5 protein in the bronchial mucosa.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D001999 Bronchoscopy Endoscopic examination, therapy or surgery of the bronchi. Bronchoscopic Surgical Procedures,Surgical Procedures, Bronchoscopic,Bronchoscopic Surgery,Surgery, Bronchoscopic,Bronchoscopic Surgeries,Bronchoscopic Surgical Procedure,Bronchoscopies,Surgeries, Bronchoscopic,Surgical Procedure, Bronchoscopic
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004802 Eosinophilia Abnormal increase of EOSINOPHILS in the blood, tissues or organs. Eosinophilia, Tropical,Hypereosinophilia,Tropical Eosinophilia,Hypereosinophilias,Tropical Eosinophilias
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Saetta, and A Di Stefano, and P Maestrelli, and G Turato, and C E Mapp, and M Pieno, and G Zanguochi, and G Del Prete, and L M Fabbri
May 1996, American journal of respiratory and critical care medicine,
M Saetta, and A Di Stefano, and P Maestrelli, and G Turato, and C E Mapp, and M Pieno, and G Zanguochi, and G Del Prete, and L M Fabbri
July 2001, American journal of respiratory and critical care medicine,
M Saetta, and A Di Stefano, and P Maestrelli, and G Turato, and C E Mapp, and M Pieno, and G Zanguochi, and G Del Prete, and L M Fabbri
January 1978, Respiration; international review of thoracic diseases,
M Saetta, and A Di Stefano, and P Maestrelli, and G Turato, and C E Mapp, and M Pieno, and G Zanguochi, and G Del Prete, and L M Fabbri
December 1995, American journal of respiratory cell and molecular biology,
M Saetta, and A Di Stefano, and P Maestrelli, and G Turato, and C E Mapp, and M Pieno, and G Zanguochi, and G Del Prete, and L M Fabbri
December 2000, Chest,
M Saetta, and A Di Stefano, and P Maestrelli, and G Turato, and C E Mapp, and M Pieno, and G Zanguochi, and G Del Prete, and L M Fabbri
December 1969, British medical journal,
M Saetta, and A Di Stefano, and P Maestrelli, and G Turato, and C E Mapp, and M Pieno, and G Zanguochi, and G Del Prete, and L M Fabbri
October 1995, Thorax,
M Saetta, and A Di Stefano, and P Maestrelli, and G Turato, and C E Mapp, and M Pieno, and G Zanguochi, and G Del Prete, and L M Fabbri
March 1979, Clinical allergy,
M Saetta, and A Di Stefano, and P Maestrelli, and G Turato, and C E Mapp, and M Pieno, and G Zanguochi, and G Del Prete, and L M Fabbri
April 1987, The American journal of medicine,
M Saetta, and A Di Stefano, and P Maestrelli, and G Turato, and C E Mapp, and M Pieno, and G Zanguochi, and G Del Prete, and L M Fabbri
September 2017, Allergy,
Copied contents to your clipboard!